D
M. Abdoli et al.
Letter
Synlett
(3) Belluti, F.; Fontana, G.; Dal Bo, L.; Carenini, N.; Giommarelli, C.;
Zunino, F. Bioorg. Med. Chem. 2010, 18, 3543.
(4) Schneider, G.; Fechner, U. Nat. Rev. Drug Discovery 2005, 4, 649.
(5) León, R.; Garcia, A. G.; Marco-Contelles, J. Med. Res. Rev. 2013,
33, 139.
(23) Nemati, F.; Elhampour, A.; Farrokhi, H.; Natanzi, M. B. Catal.
Commun. 2015, 66, 15.
(24) Afraj, S. N.; Chen, C.; Lee, G.-H. RSC Adv. 2014, 4, 26301.
(25) Berrichi, A.; Bachir, R.; Benabdallah, M.; Choukchou-Braham, N.
Tetrahedron Lett. 2015, 56, 1302.
(6) Bolea, I.; Gella, A.; Unzeta, M. J. Neural Transm. 2013, 120, 893.
(7) Zheng, H.; Fridkin, M.; Youdim, M. B. Neurochem. Res. 2010, 35,
2117.
(8) McCormack, P. L. CNS Drugs 2014, 28, 1083.
(9) Koepp, M. J.; Patsalos, P. N.; Sander, J. W. Epilepsy Res. 2002, 50,
277.
(10) Shen, C.-H.; Wang, Y.-F.; Kovalevsky, A. Y.; Harrison, R. W.;
Weber, I. T. FEBS J. 2010, 277, 3699.
(11) Wonnenberg, B.; Tschernig, T.; Voss, M.; Bischoff, M.; Meier, C.;
Schirmer, S. H.; Langer, F.; Bals, R.; Beisswenger, C. Int. J. Med.
Microbiol. 2014, 304, 725.
(26) Peshkov, V. A.; Pereshivko, O. P.; Van der Eycken, E. V. Chem. Soc.
Rev. 2012, 41, 3790.
(27) N-Benzyl-N-(4-aryl-4-morpholin-4-ylbut-2-yn-1-yl)-4-tolue-
nesulfonamides (8a–g); General Procedure
Morpholine (7; 1 mmol), the appropriate aldehyde 6 (1 mmol),
and the appropriate N-propargylsulfonamide 5 (1 mmol) were
added to a suspension of CuI (0.1 mmol) and K2CO3 (0.1 mmol)
in toluene (4.0 mL), and the mixture was stirred at 110 °C for 48
h. When the reaction was complete (TLC), the product was puri-
fied by column chromatography [silica gel, hexane–EtOAc
(4:1)].
(12) Johnson, B. K.; Colvin, C. J.; Needle, D. B.; Mba Medie, F.;
Champion, P. A. D.; Abramovitch, R. B. Antimicrob. Agents
Chemother. 2015, 59, 4436.
(13) Smith, S. W.; Fu, G. C. Angew. Chem. 2008, 120, 9474.
(14) Hattori, G.; Sakata, K.; Matsuzawa, H.; Tanabe, Y.; Miyake, Y.;
Nishibayashi, Y. J. Am. Chem. Soc. 2010, 132, 10592.
(15) Miyake, Y.; Uemura, S.; Nishibayashi, Y. ChemCatChem 2009, 1,
342.
N-Benzyl-N-(4-morpholin-4-yl-4-phenylbut-2-yn-1-yl)-4-
toluenesulfonamide (8a)
Yellow oil; yield: 412 mg (87%). 1H NMR (400 MHz, CDCl3): δ =
2.35–2.40 (m, 7 H), 3.68–3.72 (m, 4 H), 4.14–4.20 (ABdd, J =
18.6, 2.0 Hz, 2 H), 4.41 (br s, 1 H), 4.43 (ABd, J = 14.0 Hz, 1 H),
4.48 (ABd, J = 14.0 Hz, 1 H), 7.24 (d, J = 8.0 Hz, 2 H), 7.34–7.40
(m, 10 H), 7.84 (d, J = 6.6 Hz, 2 H). 13C NMR (100 MHz, CDCl3):
δ = 21.55, 35.95, 49.69, 50.02, 61.44, 66.90, 80.75, 81.53, 127.78,
127.94, 128.17, 128.23, 128.37, 128.38, 128.73, 128.76, 129.67,
134.99, 136.25, 143.50.
(16) Olivi, N.; Spruyt, P.; Peyrat, J.-F.; Alami, M.; Brion, J.-D. Tetrahe-
dron Lett. 2004, 45, 2607.
(17) Koradin, C.; Polborn, K.; Knochel, P. Angew. Chem. Int. Ed. 2002,
41, 2535.
(18) Koradin, C.; Gommermann, N.; Polborn, K.; Knochel, P. Chem.
Eur. J. 2003, 9, 2797.
(19) Periasamy, M.; Obula Reddy, P.; Satyanarayana, I.; Mohan, L.;
Edukondalu, A. J. Org. Chem. 2016, 81, 987.
(20) Zani, L.; Bolm, C. Chem. Commun. 2006, 4263.
(21) Li, Z.; Jiang, Z.; Su, W. Green Chem. 2015, 17, 2330.
(22) Price, G. A.; Brisdon, A. K.; Flower, K. R.; Pritchard, R. G.; Quayle,
P. Tetrahedron Lett. 2014, 55, 151.
N-Benzyl-N-[4-morpholin-4-yl-4-(4-tolyl)but-2-yn-1-yl]-4-
toluenesulfonamide (8b)
Yellow oil; yield: 405 mg (83%). 1H NMR (400 MHz, CDCl3): δ =
2.33–2.36 (m, 7 H), 2.39 (s, 3 H), 3.68–3.76 (m, 4 H), 4.13–4.19
(ABdd, J = 18.8, 2.0 Hz, 2 H), 4.28–4.35 (br s, 1 H), 4.41 (ABd, J =
14.0 Hz, 1 H), 4.47 (ABd, J = 14.0 Hz, 1 H), 7.15 (d, J = 8.0 Hz, 2 H),
7.21–7.26 (m, 4 H), 7.33–7.40 (m, 5 H), 7.83 (d, J = 8.4 Hz, 2 H).
13C NMR (100 MHz, CDCl3): δ = 21.17, 21.55, 35.97, 49.69, 50.00,
61.20, 66.93, 80.44, 81.85, 127.78, 128.16, 128.30, 128.31,
128.75, 128.91, 129.68, 134.15, 135.02, 136.28, 137.63, 143.47.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, A–D